Abstract:Cell Competition is a process by which neighboring cells compare their fitness. As a result, viable but suboptimal cells are selectively eliminated in the presence of fitter cells. In the early mammalian embryo, epiblast pluripotent cells undergo extensive Cell Competition, which prevents suboptimal cells from contributing to the newly forming organism. While competitive ability is regulated by MYC in the epiblast, the mechanisms that contribute to competitive fitness in this context are largely unknown. Here, we report that P53 and its pro-apoptotic targets PUMA and NOXA regulate apoptosis susceptibility and competitive fitness in pluripotent cells. PUMA is widely expressed specifically in pluripotent cells in vitro and in vivo . We found that P53 regulates MYC levels in pluripotent cells, which connects these two Cell competition pathways, however, MYC and PUMA/NOXA levels are independently regulated by P53. We propose a model that integrates a bifurcated P53 pathway regulating both MYC and PUMA/NOXA levels and determines competitive fitness. Cells compete with neighbors for survival in several situations in vitro and in vivo . In mammalian embryos, this phenomenon takes place among pluripotent cells, which are those able to form all the tissues of a new organism. Cell Competition in this context is thought to function as a quality check for the elimination of potentially damaged or dangerous cells (losers) whenever "fitter" cells (winners) are present. Here, we explored the molecular features of winner and loser pluripotent cells and uncovered a pathway that drives the ability of cells to compete. This pathway is governed by p53, a known factor that responds to stress and modulates cell death in several contexts, including cancer. Downstream this pathway, we found that p53 controls Cell Competition by regulating two independent branches; one involving the regulation of MYC, an oncogene previously known to regulate Competition in pluripotent cells, and a second one involving two mitochondrial factors known to regulate cell death and metabolism. Our work uncovers new mechanisms of pluripotent cell competition and show that the p53 cellular stress response pathway is involved in this developmental process.

Foxo3-mediated physiological cell competition ensures robust tissue patterning throughout vertebrate development

Lateral Inhibition in Cell Specification Mediated by Mechanical Signals Modulating TAZ Activity

An ancient defense system eliminates unfit cells from developing tissues during cell competition

Evolutionarily conserved roles of foxg1a in the developing subpallium of zebrafish embryos

Flamingo participates in multiple models of cell competition

Stem cell competition driven by the Axin2-p53 axis controls brain size during murine development

Foxm1 regulates cardiomyocyte proliferation in adult zebrafish after cardiac injury.

Fox Proteins Are Modular Competency Factors For Facial Cartilage And Tooth Specification

Cell competition: emerging signaling and unsolved questions

Foxm1 drives cardiomyocyte proliferation in adult zebrafish after cardiac injury

Cell competition constitutes a barrier for interspecies chimerism

Cell competition and the regulation of protein homeostasis

Chronic activation of JNK JAK/STAT and oxidative stress signalling causes the loser cell status

P53 and BCL-2 family proteins PUMA and NOXA define competitive fitness in pluripotent cell competition

Foxc1 Establishes Enhancer Accessibility for Craniofacial Cartilage Differentiation.

Zebrafish Foxc1a Plays a Crucial Role in Early Somitogenesis by Restricting the Expression of Aldh1a2 Directly.

A critical role of foxp3a-positive regulatory T cells in maintaining immune homeostasis in zebrafish testis development

Foxk1 Promotes Cell Proliferation and Represses Myogenic Differentiation by Regulating Foxo4 and Mef2.

Cell competition: the winners and losers of fitness selection

Zebrafish Foxo3b Negatively Regulates Canonical Wnt Signaling to Affect Early Embryogenesis.